Determination of intracellular antibody production, cell density, and viability of recombinant CHO-DG44 cells using the MACSQuant® Analyzer
© Pluschke et al; licensee BioMed Central Ltd. 2011
Published: 22 November 2011
Expression of recombinant antibodies in CHO cells is a state-of-the-art procedure in research and industry. Generation of cell lines producing high amounts of antibodies is one of the major tasks to increase process efficiency. The establishment of clones is often achieved by methotrexate (MTX)–mediated gene amplification in CHO-DG44 cells. Evaluation of MTX-mediated amplification is usually facilitated by intracellular staining of CHO cells.
We used the MACSQuant® Analyzer to determine the fraction of antibody-producing cells following staining of intracellular IgG with fluorochrome-conjugated antibodies. Additionally, the instrument was utilized for the rapid and reproducible determination of cell density and viability.
Materials and methods
Cell density and viability measurements
Cell density and viability were determined by using the MACSQuant Analyzer. The data were compared to those obtained with other commercially available cell-counting devices (Cedex, Roche Diagnostics; Vi-Cell, Beckman Coulter). Dead cell exclusion for flow cytometric analysis with the MACSQuant Analyzer was achieved by propidium iodide (PI) staining. In contrast, the automated cell viability analyzers used video imaging and the trypan blue dye exclusion method for dead cell discrimination.
Gene amplification in culture
For amplification of the target gene, a transfectant pool of CHO DG44 cells was grown in a perfused 1-L bioreactor with increasing MTX concentrations. Up to 150% of the culture volume was exchanged daily. MTX concentration was doubled every 7 to 14 days depending on cell viability.
Intracellular IgG staining of CHO cells
Permeabilization of the cell membrane with detergents allowed intracellular staining of the IgG-producing CHO cell pools. IgG+ cells were stained with fluorochrome-conjugated antibodies that bind to Fc and kappa chains of IgG within fixed CHO cells.
Comparative measurement of cell density and viability using the MACSQuant Analyzer and automated cell viability analyzers
The MACSQuant Analyzer was used to monitor a bioreactor process in comparison to two different automated cell viability analyzers (Cedex, Vi-Cell). We used cells from a fed-batch bioreactor process, cultivated in a benchtop system. Samples were diluted in the same manner for all monitoring systems.
Viable cell density (VCD) and cell viabilities of CHO cells cultured in a fed-batch bioreactor process
Process time (d)
VCD mean (cells/mL)
Viability mean (%)
The three methods yielded results with similar general trends, although measurements with the MACSQuant Analyzer showed lower total (and viable) cell densities compared to the Cedex and Vi-Cell instruments. This was likely due to flow cytometric gating of a particular cell population and the use of a threshold to exclude debris. The Cedex and Vi-Cell instruments, however, might still determine small debris particles as cells.
At high cell densities, the standard dilution factor was not suitable for the MACSQuant Analyzer, as it resulted in an elevated events-per-second ratio. Therefore, higher dilutions were applied, which allowed better comparability to the other analyzers (data not shown). Cell viability results obtained with the MACSQuant Analyzer were similar to the results from automated cell analyzers, even though the measurement is based on a different method.
Gene amplification monitoring by intracellular staining
Intracellular IgG production was used as an indirect parameter to monitor MTX-induced gene amplification. Usually, gene amplification is performed at a clonal level. We followed a different, possibly less time-consuming approach using cell pools.
Another gene amplification was more stable with regard to the intracellular antibody content. There was an increase in the fraction of IgG-producing cells at the beginning, followed by a stable phase with fractions of more than 90% IgG-producing cells throughout the whole amplification (data not shown). This gene amplification allowed us to generate a high-producer pool in a perfused bioreactor. In contrast, the amplification shown in figure 1 did not yield a high-producer pool as non-producing cells overgrew the producing cells.
The MACSQuant Analyzer is a powerful tool for the evaluation of gene amplification. Intracellular staining provides an in-depth insight into the stability of the cell pool and allows the assessment of amplification efficiency. Despite high concentrations of MTX, a transfectant pool with 20% IgG-producing cells was overgrown by non-producing cells. This may be due to a saturation effect of MTX  or to an MTX resistance, caused, e.g., by altered MTX transport properties . In contrast, another pool with 90% IgG-producing cells yielded successful selection of IgG-producing cells and increased IgG titers. Amplification with MTX in a cell pool with a low starting content of IgG-producing cells is not effective.
The MACSQuant Analyzer allows the determination of cell density and viability with high reproducibility. The mean data were comparable to common cell-counting systems. The results obtained with the MACSQuant Analyzer, however, showed better accuracy as reflected by the lower CV. Moreover, through its FSC, SSC, and seven fluorescence channels, as well as its three lasers it allows sophisticated, multiparametric flow cytometric analysis.
- Cacciatore , Chasin , Leonard : Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system. Biotechnol Adv. 2010, 28 (6): 673-681. 10.1016/j.biotechadv.2010.04.003.View ArticlePubMedGoogle Scholar
- Jun , Kim , Baik , Hwang , Lee : Selection strategies for the establishment of recombinant Chinese hamster ovary cell line with dihydrofolate reductase-mediated gene amplification. Appl Microbiol Biotechnol. 2005, 69 (2): 162-169. 10.1007/s00253-005-1972-8.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.